<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
IMMP
Immutep
$
()


  • Immutep to present clinical data from TACTI-003 Phase IIb trial

    7/3/2024 - 08:03am
  • Immutep price target lowered by $1 at Baird, here's why

    6/27/2024 - 06:42am
  • Immutep signs exclusive license agreement with Cardiff University

    6/25/2024 - 08:18am
  • Immutep enters clinical collaboration with Merck

    6/3/2024 - 05:27am
  • Capital One starts Immutep at Buy given 'pipeline in a product'

    5/17/2024 - 09:29am
  • Immutep initiated with bullish view at Capital One

    5/17/2024 - 07:10am
  • Immutep presents data from safety lead-in Phase of AIPAC-003 at ESMO Beast 2024

    5/15/2024 - 08:24am
  • Immutep announces initial data from EFTISARC-NEO

    5/2/2024 - 08:19am
  • Immutep announces preliminary topline results from TACTI-003 Cohort B

    4/24/2024 - 08:14am
  • Immutep engers agreement with Centre for Human Drug Research

    4/18/2024 - 08:15am
  • Immutep receives feedback from the Spanish AEMPS for TACTI-004 trial

    4/17/2024 - 08:06am
  • Immutep announces first clinical data from 90mg dosing of efti

    3/5/2024 - 08:08am
  • Immutep reports Q2 cash receipts $38K vs. $132K last quarter

    1/30/2024 - 08:16am
  • Immutep announces first patient enrolled, dosed in INSIGHT-005 trial

    1/4/2024 - 08:30am
  • Immutep receives constructive feedback on TACTI-004 trial

    12/21/2023 - 08:08am
dynamic_feed Breaking News